The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no sensitizing ...
Nov 16, 2022
0
47
COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS. This is the conclusion of a study from Linköping University ...
Nov 16, 2022
0
103
Imagine you're young, healthy and active. Then, one day, the rug is pulled out from under you. You initially have symptoms akin to a cold, so you take a lateral flow test, which shows you have COVID. But it's nothing that ...
Nov 9, 2022
0
3
The COVID pandemic has introduced many scientific and medical terms into our everyday language. Many of us are now fluent in conversations about viral strains, PCR tests and mortality rates. "Brain fog" has joined these ranks ...
Oct 25, 2022
0
25
The toll of COVID on our health care workers has been brutal, with many saying they want to quit their jobs.
Oct 5, 2022
0
0
Millions of people around the world are believed to suffer from long COVID yet little remains known about the condition—though research has recently proposed several theories for its cause.
Oct 1, 2022
0
105
Using advanced diffusion neuroimaging technology, Kessler Foundation researchers investigated the relationship between the rate of cognitive fatigue to microstructural changes in the brain in persons with multiple sclerosis. ...
Oct 1, 2022
0
18
The flow velocity in our digestive system directly determines how well nutrients are absorbed by the intestine and how many bacteria live inside it. This is the result of a new study by researchers from the Technical University ...
Sep 26, 2022
0
169
The therapeutic benefits of massage have long been recognized. A new study suggests that foot massage, in particular, can help minimize a number of common menopause symptoms, including sleep disruption, effectively extending ...
Sep 21, 2022
0
47
The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as the first treatment option for generalized pustular psoriasis (GPP) flares in adults.
Sep 7, 2022
0
1
